- Home
- ATXS vs NOA Comparison
ATXS vs NOA Comparison
Compare ATXS & NOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- NOA
- Stock Information
- Founded
- ATXS 2008
- NOA 1953
- Country
- ATXS United States
- NOA Canada
- Employees
- ATXS N/A
- NOA N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- NOA Meat/Poultry/Fish
- Sector
- ATXS Health Care
- NOA Consumer Staples
- Exchange
- ATXS Nasdaq
- NOA Nasdaq
- Market Cap
- ATXS 424.4M
- NOA 478.5M
- IPO Year
- ATXS 2015
- NOA 2006
- Fundamental
- Price
- ATXS $7.52
- NOA $14.34
- Analyst Decision
- ATXS Buy
- NOA
- Analyst Count
- ATXS 6
- NOA 0
- Target Price
- ATXS $33.00
- NOA N/A
- AVG Volume (30 Days)
- ATXS 436.6K
- NOA 102.4K
- Earning Date
- ATXS 11-12-2025
- NOA 10-29-2025
- Dividend Yield
- ATXS N/A
- NOA 2.40%
- EPS Growth
- ATXS N/A
- NOA N/A
- EPS
- ATXS N/A
- NOA 0.87
- Revenue
- ATXS N/A
- NOA $919,386,154.00
- Revenue This Year
- ATXS N/A
- NOA $16.14
- Revenue Next Year
- ATXS N/A
- NOA $3.55
- P/E Ratio
- ATXS N/A
- NOA $16.59
- Revenue Growth
- ATXS N/A
- NOA 14.15
- 52 Week Low
- ATXS $3.56
- NOA $12.12
- 52 Week High
- ATXS $12.52
- NOA $22.08
- Technical
- Relative Strength Index (RSI)
- ATXS 55.75
- NOA 56.74
- Support Level
- ATXS $6.95
- NOA $13.66
- Resistance Level
- ATXS $7.48
- NOA $14.71
- Average True Range (ATR)
- ATXS 0.42
- NOA 0.36
- MACD
- ATXS -0.01
- NOA 0.13
- Stochastic Oscillator
- ATXS 65.35
- NOA 72.39
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About NOA North American Construction Group Ltd. (no par)
North American Construction Group Ltd is Canada's heavy civil construction and mining contractor provider. The company has provided services to oil, natural gas, and resource companies. The Company provides a wide range of mining and heavy civil construction services to customer in the resource development and industrial construction sectors within Canada, the United States, and Australia. The Company's reportable segments are Heavy Equipment Canada, Heavy Equipment Australia, and Other. Heavy Equipment Canada and Heavy Equipment Australia include all of aspects of the mining and heavy civil construction services provided within those geographic areas. Other includes mine management contract work in the United States, its external maintenance and rebuild programs.